Ballentine Partners, LLC Astrazeneca PLC Transaction History

Ballentine Partners, LLC

$5.81 Billion
Q4 2024

A detailed history of Ballentine Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Ballentine Partners, LLC holds 30,522 shares of AZN stock, worth $2.03 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

30,522

Previous 32,291 5.48%

Holding current value

$2.03 Million

Previous $2.52 Million 20.55%

% of portfolio

0.03%

Previous 0.04%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 16, 2025	SELL	$63.2 - $79.58 $111,800 - $140,777	-1,769 Reduced 5.48%	30,522 $2 Million
Q3 2024 Oct 23, 2024	BUY	$76.67 - $87.62 $273,251 - $312,277	3,564 Added 12.41%	32,291 $2.52 Million
Q2 2024 Aug 06, 2024	BUY	$66.81 - $80.83 $341,532 - $413,202	5,112 Added 21.65%	28,727 $2.24 Million
Q1 2024 Apr 11, 2024	BUY	$61.03 - $69.57 $353,668 - $403,158	5,795 Added 32.52%	23,615 $1.6 Million
Q4 2023 Jan 23, 2024	BUY	$61.89 - $69.28 $143,894 - $161,076	2,325 Added 15.0%	17,820 $1.2 Million
Q3 2023 Oct 19, 2023	SELL	$64.85 - $71.7 $19,455 - $21,510	-300 Reduced 1.9%	15,495 $1.05 Million
Q2 2023 Jul 26, 2023	BUY	$69.91 - $75.81 $263,490 - $285,727	3,769 Added 31.34%	15,795 $1.13 Million
Q1 2023 Apr 27, 2023	SELL	$63.15 - $71.6 $2,526 - $2,864	-40 Reduced 0.33%	12,026 $834,000
Q4 2022 Jan 27, 2023	BUY	$54.21 - $70.44 $173,146 - $224,985	3,194 Added 36.0%	12,066 $0
Q3 2022 Oct 26, 2022	SELL	$53.02 - $135.75 $24,654 - $63,123	-465 Reduced 4.98%	8,872 $487,000
Q2 2022 Aug 09, 2022	BUY	$59.26 - $71.14 $107,082 - $128,549	1,807 Added 24.0%	9,337 $618,000
Q1 2022 May 05, 2022	BUY	$55.72 - $67.12 $1,281 - $1,543	23 Added 0.31%	7,530 $499,000
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $16,800 - $19,851	-311 Reduced 3.98%	7,507 $437,000
Q3 2021 Oct 27, 2021	BUY	$55.56 - $60.79 $35,836 - $39,209	645 Added 8.99%	7,818 $470,000
Q2 2021 Aug 12, 2021	BUY	$48.42 - $60.18 $290 - $361	6 Added 0.08%	7,173 $430,000
Q1 2021 May 11, 2021	BUY	$47.16 - $54.44 $15,232 - $17,584	323 Added 4.72%	7,167 $356,000
Q4 2020 Jan 25, 2021	SELL	$48.52 - $58.02 $23,774 - $28,429	-490 Reduced 6.68%	6,844 $342,000
Q3 2020 Oct 22, 2020	BUY	$53.07 - $61.1 $28,180 - $32,444	531 Added 7.81%	7,334 $402,000
Q2 2020 Jul 31, 2020	BUY	$43.1 - $55.31 $10,085 - $12,942	234 Added 3.56%	6,803 $360,000
Q1 2020 Apr 23, 2020	BUY	$37.79 - $51.33 $2,380 - $3,233	63 Added 0.97%	6,569 $293,000
Q4 2019 Jan 22, 2020	BUY	$42.46 - $50.46 $34,689 - $41,225	817 Added 14.36%	6,506 $324,000
Q3 2019 Oct 21, 2019	BUY	$40.12 - $45.47 $6,659 - $7,548	166 Added 3.01%	5,689 $254,000
Q2 2019 Jul 25, 2019	BUY	$37.28 - $41.68 $205,897 - $230,198	5,523 New	5,523 $228,000

Others Institutions Holding AZN

# of Institutions

1,349

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $206B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballentine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ballentine Partners, LLC with notifications on news.

Account

Ballentine Partners, LLC Astrazeneca PLC Transaction History